Explore Stanford technologies available for licensing:

The Hong Neurotechnology Lab at Stanford University developed ultrasound-activated nanoscopic light emitters (mechanoluminescent nanoparticles) that are delivered via the blood stream, unlike conventional optogenetics approaches that require invasive fiber optic implants.

A team of Stanford researchers has developed ReMatch, an efficient, data-driven DER (distributed energy resources) planning and decision support framework that accounts for a range of complexities to optimize energy resource planning.

Stanford researchers at the Vuckovic Lab have developed a full chip-scale integration of a Ti:Sapphire laser system which dramatically reduces the size, cost, and power consumption by many orders of magnitude, compared to today's state-of-the-art systems which are bulky and ex

Researchers in Prof. A.C. Matin's laboratory have developed a versatile exosome (extracellular vesicle, "EV") drug delivery platform that can selectively target therapeutic agents to tumors or other tissues that overexpress extracellular receptors.

Researchers at Stanford have developed agents to enhance the therapeutic efficacy of a variety of anti-cancer therapeutics. Cell loss by apoptosis occurs in normal development and in tumor environments.

Stanford researchers have developed a rapid, accurate, and accessible method to test for food allergy and other types of allergy.

Researchers at Stanford have developed a software application solution to the spatial computing problem of aligning virtual content to the real world.

Researchers at Stanford have shown that two CRISPR-Cas nucleases, Cas9 and Cpf1, can be programmed to produce efficient RNA-guided nickases.

Disease Indication Oncology, hematological cancers, breast cancer, solid tumors

Drug Format Cell therapy

Drug Class Best-in-class

Target CD19, HER2, B7-H3, GPC2 and all other tumor antigens

Stanford researchers have developed a low cost, safe, environmentally friendly, rechargeable Zn/MnO₂ flow battery with the potential for grid scale energy storage.

Researchers in Dr. Mark Kay's lab have developed a patented approach to inducing apoptosis that could represent a new strategy against cancer and other diseases.

Stanford researchers at the Prakash Lab have developed Octopi, a low-cost ($250-$500) and reconfigurable autonomous microscopy platform capable of automated slide scanning and correlated bright-field and fluorescence imaging.

Researchers at Stanford have developed a device capable of delivering ultrasonic neuromodulation to defined areas of the brain while simultaneously recording neuronal activity with cell-type specificity.

This bandage-like multi-lead, continuous ECG monitoring device uses new stretchable electrode material developed in the Bao group to accurately and imperceptibly diagnose cardiac arrhythmia.

Researchers at Stanford have developed methods to improve the diagnosis of narcolepsy. Narcolepsy is a disorder in which people experience excessive sleepiness and uncontrollable episodes of falling asleep.